芪明颗粒治疗不同眼底出血的临床观察

Clinical observation of Qi-ming granule in treatment of various fundus hemorrhages

目的观察芪明颗粒治疗几种眼底出血的临床疗效;方法：回顾性研究,在治疗68例患者（94眼）由不同原发病（视网膜静脉阻塞、糖尿病视网膜病变、高血压视网膜病变（造成眼底出血,随机分为治疗组和对照组,分别给予芪明颗粒口服,3个疗程后,根据视力、眼底、视野检查及荧光血管造影观察疗效;结果：芪明颗粒治疗组对于视网膜静脉阻塞、糖尿病视网膜病变和高血压视网膜病变引起眼底出血疗效优于对照组（P〈0.05）,总有效率分别为75%、86%和87%.治疗过程中未见明显毒副作用;结论：芪明颗粒治疗视网膜静脉阻塞、糖尿病视网膜病变和高血压视网膜病变造成眼底出血安全疗效.

AIM To observe the clinical efficacy of Qi-ming granule in treatment of various fundus hemorrhages. METHODS： Retrospectively, 68 patients （94 eyes） withvarious fundus hemorrhages caused by primary diseases were divided into 2 groups and accepted treatment of oral Qi-ming granule regime or vitamins as control, respectively. Theseprimary diseases included retinal vein occlusion （RVO）, diabetic retinopathy （DRP） and hypertensive retinopathy （HRP）. After 3 treatment courses, vision acuity, fundus photo, visualfield test and fluorescein angiography were recorded and analyzed to estimate efficacy of the tablets. RESULTS： The fundus hemorrhages treated by Qi-ming granule showed betterthan that in control group. The total effective rates of fundus hemorrhage by RVO, DRP and HRP were up to 75%, 86% and 87%, respectively. There was no obvious side-effect intreatment courses.CONCLUSION： Qi-ming granule is safe and effective in treating fundus hemorrhages caused by RVO, DRP and HRP.